SCHEMBL7703050

SCHEMBL7703050

CCOc1cccc(-c2cc(N)nc(N)c2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S1PR1 P21453 3/20 0.56
▸ NOTUM Q6P988 1/20 0.56
▸ TP53 P04637 3/20 0.56
▸ CYP3A4 P08684 1/20 0.56
▸ MAP4K4 O95819 1/20 0.56
▸ FGFR2 P21802 2/20 0.54
▸ FGFR3 P22607 2/20 0.54
▸ FGFR1 P11362 1/20 0.54
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ RXRA P19793 1/20 0.51
▸ RXRB P28702 1/20 0.51
▸ MAPT P10636 3/20 0.50
▸ KDM4E B2RXH2 2/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ HPGD P15428 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ CASP3 P42574 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ SENP8 Q96LD8 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9260410 0.84 RXRA (0.66) S1PR1NOTUMTP53CYP3A4MAP4K4
SCHEMBL29426410 0.84 RXRA (0.66) S1PR1NOTUMTP53CYP3A4MAP4K4
SCHEMBL29012837 0.82 RXRA (0.64) S1PR1NOTUMTP53CYP3A4MAP4K4
SCHEMBL7705899 0.81 KMT2A (0.57) CYP3A4MAP4K4KDM4EALDH1A1HPGD
SCHEMBL3793225 0.81 CYP3A4 (0.79) S1PR1NOTUMTP53CYP3A4MAP4K4
SCHEMBL30093058 0.81 CYP3A4 (0.79) S1PR1NOTUMTP53CYP3A4MAP4K4
SCHEMBL1337788 0.79 TP53 (0.65) NOTUMTP53CYP3A4MAP4K4FGFR2
SCHEMBL1337634 0.79 TP53 (0.54) S1PR1NOTUMTP53CYP3A4MAP4K4
SCHEMBL1335616 0.79 TP53 (0.54) S1PR1NOTUMTP53CYP3A4MAP4K4
SCHEMBL30338775 0.78 RXRA (0.70) NOTUMTP53CYP3A4MAP4K4FGFR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6355653-B1 DRUG AND CARRIER FOR ANTIALLERGENS, BRAIN DISORDERS AND NEUROTRANSMITTERS HOFFMANN-LA ROCHE INC. 2002-03-12 — — US disclosed
Send feedback